Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.25.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XADNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XABNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FT.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XALNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBWNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GY.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GA.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CT.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.10.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.8.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBSNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAHNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.256NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.7 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.460NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.262NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBUNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.351.5 (Beta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FZ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.9.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.6.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.4.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JB.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DV.7.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.30.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.68NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.425NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used